This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Peptidream Inc., The University of Tokyo. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12 
1 out of 1,358 
Years Active: 2017
Title: The Innovations of Takahiro Ishizawa
Introduction
Takahiro Ishizawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of peptides that inhibit vascular endothelial growth factor receptors. His work is characterized by a focus on specificity and cost-effectiveness.
Latest Patents
Ishizawa holds a patent for a peptide designed to inhibit the vascular endothelial growth factor receptor 2 (VEGFR2). The invention aims to provide a VEGFR2 inhibitor peptide that is both highly specific and available at a low cost. The patent details a peptide with a specific amino acid sequence, which includes various derivatives of amino acids such as Val, Asp, Pro, Trp, Asn, Gly, and Leu.
Career Highlights
Throughout his career, Ishizawa has been associated with prestigious institutions, including the University of Tokyo and Peptidream Inc. His work has contributed to advancements in medical research and therapeutic applications.
Collaborations
Ishizawa has collaborated with notable colleagues, including Hiroshi Murakami and Takashi Kawakami. These partnerships have enhanced the scope and impact of his research.
Conclusion
Takahiro Ishizawa's innovative work in peptide development showcases his commitment to advancing biotechnology. His contributions are significant in the pursuit of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile